Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

True Health Diagnostics Marks Lung Cancer Awareness Month with Call for Earlier-Detection, Smoking Cessation

True Health Diagnostics
Posted on: 29 Nov 16

FRISCO, Texas, Nov. 28, 2016 /PRNewswire/ -- True Health is supporting November's Lung Cancer Awareness Month by calling for a renewed effort for smoking cessation and greater awareness among high-risk patients for early lung cancer testing. More than 16 percent of U.S. adults are active smokers and more than 21 percent are ex-smokers. For high-risk patients, True Health's EarlyCDT-Lung blood test has the potential to signal the presence of cancer up to four years earlier than other methods of cancer detection.

Patients at high risk for lung cancer who take advantage of the True Health EarlyCDT-Lung test submit blood samples that are tested for elevated levels of seven autoantibodies validated against lung cancer. 

Elevated levels of any one of these antibodies above a predetermined cut-off suggests that a tumor might be present.

"Lung cancer is one of the more treatable cancers, if caught early – a patient can have up to a 90 percent survival rate," said True Health Diagnostics CEO Chris Grottenthaler. "We urge doctors to work with patients to develop smoking cessation plans and make use of the EarlyCDT-Lung test to assess the risk that certain patients face in developing lung cancer. Healthcare professionals now may be able to detect the antibodies produced when tumor cells are present in the lungs, before the tumor itself is detectable."  

Almost 80 percent of lung cancer is diagnosed after it has spread to other organs. EarlyCDT-Lung detects lung cancer earlier, with an overall specificity of 93 percent and accuracy of 92 percent. Without the benefit of EarlyCDT-Lung test results, lung cancer may not be detected until later stages.

"There are more than 480,000 smoking-related deaths in the U.S. every year. It is a major modifiable risk factor for both lung cancer and heart disease. True Health encourages patients to make use of smoking cessation techniques and, if necessary, to know their risk by asking a physician for an EarlyCDT-Lung test," said Grottenthaler.

About True Health Diagnostics

True Health Diagnostics is a health services company, providing innovative clinical services and diagnostic information to help people live longer, healthier lives. The company specializes in earlier-stage prevention and diagnosis of chronic disease, including cardiovascular, diabetes, cancer, genetic disorders and a range of metabolic conditions. True Health is a trusted partner of medical professionals because we help them obtain accurate and necessary diagnoses that can improve patient care. True Health is headquartered in Frisco, Texas, with operations across the country. More information can be found at truehealthdiag.com.

Media Contact:
Lon Wagner
Vice President, Communications
(540) 556-2994

For more information:
truehealthdiag.com

Editor's Details

Mike Wood
PharmiWeb.com
www.pharmiweb.com
editor@pharmiweb.com

Last updated on: 29/11/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.